Russell Dahl,Ah Young Lee,Changwon Kho,Roger J. Hajjar
申请号：
US15826238
公开号：
US20180127407A1
申请日:
2017.11.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided are SUMO activators, which can enhance SUMOylation of SERCA2a, which are useful in the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infection, bacterial infection, liver disease, inflammation, and other diseases.
